ASG Superconductors with HZDR researchers combine magnetic resonance imaging with particle beams
ASG Superconductors with researchers of the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world’s first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy. They are combining a rotating open MRI device for the LINAC-MR system Alberta Health Services, with an actively scanned clinical-akin proton beam at OncoRay, the Dresden-based National Center for Radiation Research in Oncology. The rotating MRI device is produced by ASG Superconductors, using the MROpen Evo technology-based helium-free superconducting magnesium diboride (MgB2) magnet. Real-time MRI would make it possible to synchronize the proton beam to tumor motion during radiation dose delivery. So far, this has been impossible and therefore was a limiting factor for treating moving tumors with this promising cancer therapy.
NEWS
MROpenEVO @ ARAB HEALTH 23
Spreading the best mri experience advantages enabled by MROpenEVO to [...]
Three new MROpen EVO in the USA
US Radiology Specialists Enhances Imaging Capabilities at its American [...]
SHOWCASING MROpenEVO @ RSNA 22
The best MRI experience will be @ RSNA 2022. Also [...]
MROpen EVO @Sirm 2022
Looking forward to meet the MRI and radiology community in [...]
MROpenEvo: the next generation in positional MR imaging
The MROpen EVO is the world's only superconducting, cryogen-free [...]
DISCOVER MORE
